This study demonstrates the conversion of plastic bottles into levodopa using engineered bacteria, highlighting a novel approach to sustainable drug production.
An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent publication in the scientific journal Nature Medicine, they describe the discovery of a new quantitative biomarker in lumbar fluid (cerebrospinal fluid) that is helping doctors to diagnose Parkinson's disease and Lewy body dementia more accurately.
Doctors often struggle to distinguish early dementia with Lewy bodies from early Parkinson's disease.
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of
our websites
and requested to be notified of additional information.
